• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down3.39% Nasdaq Down4.12%

    Repros Therapeutics Inc. (RPRX)

    -NasdaqCM
    1.57 Down 0.13(7.65%) Jun 24, 4:00PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development24,116  27,107  23,657  
    Selling General and Administrative5,087  5,437  4,818  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (29,203) (32,544) (28,475)
    Income from Continuing Operations
    Total Other Income/Expenses Net11  9  9  
    Earnings Before Interest And Taxes(29,192)(32,535)(28,466)
    Interest Expense -   -   -  
    Income Before Tax(29,192)(32,535)(28,466)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(29,192)(32,535)(28,466)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (29,192) (32,535) (28,466)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (29,192) (32,535) (28,466)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.